Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 10/20 | 0.36 |
| ▸ | CNR2 | P34972 | 9/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.35 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29279397 | 0.80 | ALOX15 (0.43) | ALOX15TP53CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL29400338 | 0.77 | ALOX15 (0.43) | ALOX15TP53CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL39144 | 0.77 | ALOX15 (0.43) | ALOX15TP53CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL5086030 | 0.77 | ALOX15 (0.49) | ALOX15TP53CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL29421162 | 0.76 | ALOX15 (0.46) | ALOX15TP53CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL78065 | 0.76 | ALOX15 (0.46) | ALOX15TP53CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL464938 | 0.75 | ALOX15 (0.42) | ALOX15TP53CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL9351488 | 0.75 | ALOX15 (0.45) | ALOX15TP53CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL7748636 | 0.74 | ALOX15 (0.46) | ALOX15TP53CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL97186 | 0.74 | ALOX15 (0.46) | ALOX15TP53CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103652-A1 | MACROMOLECULAR CORROSION (McIn) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | POLNOX CORP (US) | 2026-04-16 | — | — | US | disclosed |
| US-12492352-B2 | Macromolecular corrosion (MCIN) inhibitors: structures, methods of making and using the same | POLNOX CORPORATION (US) | 2025-12-09 | — | — | US | disclosed |
| US-20230159841-A1 | MACROMOLECULAR CORROSION (MCIN) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | POLNOX CORPORATION | 2023-05-25 | — | — | US | disclosed |
| US-11578285-B2 | Macromolecular corrosion (McIn) inhibitors: structures, methods of making and using the same | POLNOX CORPORATION (US) | 2023-02-14 | — | — | US | disclosed |
| EP-3071544-B1 | MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES METHODS OF MAKING AND USING THE SAME | POLNOX CORP (US) | 2022-07-06 | — | — | EP | disclosed |
| US-11060027-B2 | Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same | POLNOX CORPORATION (US) | 2021-07-13 | — | — | US | disclosed |
| US-20210130722-A1 | MACROMOLECULAR CORROSION (MCIN) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | POLNOX CORPORATION | 2021-05-06 | — | — | US | disclosed |
| US-20200392406-A1 | MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES, METHODS OF MAKING AND USING THE SAME | POLNOX CORPORATION | 2020-12-17 | — | — | US | disclosed |
| US-10683455-B2 | Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same | POLNOX CORPORATION (US) | 2020-06-16 | — | — | US | disclosed |
| US-20190292454-A1 | Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same | POLNOX CORPORATION | 2019-09-26 | — | — | US | disclosed |
| US-5073278-A | Oxidation resistant | CIBA-GEIGY CORPORATION (US) | 1991-12-17 | — | — | US | disclosed |
| US-5002698-A | Anti-Wear Agents, Extreme Pressure Additives | CIBA-GEIGY CORPORATION (US) | 1991-03-26 | — | — | US | disclosed |
| US-4963276-A | MIXTURE OF AROMATIC AMINE AND ORGANOSULFUR COMPOUND | CIBA-GEIGY CORPORATION (US) | 1990-10-16 | — | — | US | disclosed |
| EP-0391649-A2 | Improved ashless lubricant compositions for internal combustion engines | EXXON CHEMICAL PATENTS INC. (US) | 1990-10-10 | — | — | EP | disclosed |
| EP-0391651-A2 | Improved low ash lubricant composition for internal combustion engines | EXXON CHEMICAL PATENTS INC. (US) | 1990-10-10 | — | — | EP | disclosed |
| US-4925580-A | HYDRALIC OILS; CORROSION AND WEAR RESISTANCE | CIBA-GEIGY CORPORATION (US) | 1990-05-15 | — | — | US | disclosed |
| US-4917809-A | OIL-SOLUBLE 5-MEMBERED RING HETEROCYCLIC COMPOUND, WHICH MAY BE BENZO-FUSED, AND PHOSPHORUS COMPOUND | CIBA-GEIGY CORPORATION (US) | 1990-04-17 | — | — | US | disclosed |
| US-4863621-A | WEAR RESISTANCE, EXTREME PRESSURE LUBRICANTS | CIBA-GEIGY CORPORATION (US) | 1989-09-05 | — | — | US | disclosed |
| US-4737300-A | LUBRICANTS, STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1988-04-12 | — | — | US | disclosed |
| EP-0220136-A2 | Boric-acid complexes | CIBA-GEIGY AG (CH) | 1987-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11060027-B2 | Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same | LPO, GPX4, DUOX2 | ALOX15 479/4885TP53 2027/4885CYP2D6 627/4885 |
| US-11578285-B2 | Macromolecular corrosion (McIn) inhibitors: structures, methods of making and using the same | MB, NCLN, CPN1 | ALOX15 1763/4885TP53 2097/4885CYP2D6 4120/4885 |
| US-10683455-B2 | Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same | LPO, GPX4, DUOX2 | ALOX15 479/4885TP53 2027/4885CYP2D6 627/4885 |
| US-20210130722-A1 | MACROMOLECULAR CORROSION (MCIN) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | MB, NCLN, CPN1 | ALOX15 1763/4885TP53 2097/4885CYP2D6 4120/4885 |
| US-20190292454-A1 | Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same | LPO, GPX4, DUOX2 | ALOX15 479/4885TP53 2027/4885CYP2D6 627/4885 |
| US-20200392406-A1 | MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES, METHODS OF MAKING AND USING THE SAME | LPO, GPX4, DUOX2 | ALOX15 479/4885TP53 2027/4885CYP2D6 627/4885 |
| US-12492352-B2 | Macromolecular corrosion (MCIN) inhibitors: structures, methods of making and using the same | MB, NCLN, CPN1 | ALOX15 1763/4885TP53 2097/4885CYP2D6 4120/4885 |
| US-20260103652-A1 | MACROMOLECULAR CORROSION (McIn) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | MPO, CYC1, CBR1 | ALOX15 1702/4885TP53 2544/4885CYP2D6 2312/4885 |
| US-20230159841-A1 | MACROMOLECULAR CORROSION (MCIN) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | MB, NCLN, CPN1 | ALOX15 1763/4885TP53 2097/4885CYP2D6 4120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.